Many lines of evidence exist associating herpes simplex virus (HSV) with the development of carcinoma, but much of this evidence is anecdotal or associative in nature and does not prove a cause and effect. The purpose of this research was to investigate the oncogenic potential of HSV type 2 (HSV-2) in vivo. A mouse model for lip carcinogenesis was designed to combine HSV-2 infection, u.v. exposure and tetradecanoyl-phorbol-acetate (TPA) application. HSV-2 inoculation on to abraded mouse lips was capable of causing vesicular ulcerative lesions which healed completely after 10 to 14 days. Ultraviolet irradiation of the HSV lesion site daily for 6 min at 42 ergs/mmVs on days 3 to 6 post-infection caused hyperkeratosis, acanthosis and dyslblasia to develop in several lips; while the same u.v. exposure by itself failed to alter the histologic appearance. The addition of repeated TPA application to the HSV+ u.v. regimen promoted tumour emergence. Thirty-two of 156 Balb/c mice developed tumours. Although the majority were papillomas, six were squamous cell carcinomas. These tumour-bearing mice had increased HSV-specific antibody titres. HSV antigens were shown to be present in outgrowths from explanted tumours as well as in tumour biopsies by immunoperoxidase staining with HSV-specific antisera. It is suggested that the in vivo u.v.-irradiated HSV acted as the inducer and TPA as the promoter, analogous to the classical two-stage carcinogenesis model.
INTRODUCTION
Scientific attempts to demonstrate the oncogenic nature of herpes simplex virus (HSV) began soon after epidemiologic studies revealed a positive correlation between previous HSV genital infection and the development of uterine cervical carcinoma (for review, see Rapp, 1978) . About the same time, a British physician reported six cases of squamous cell carcinoma of the lip in locations that had suffered from recurrent herpes labialis (Wyburn-Mason, 1957) . Since these beginnings, many avenues of research have been followed investigating the oncogenic potential of HSV, including epidemiologic, virus marker, site analysis, in vitro transformation and biochemical studies.
Epidemiologically, neutralizing antibodies to HSV, assayed by either the kinetics of neutralization or by neutralization titres, are significantly higher in women with cervical cancer as opposed to an age-matched control group (Adam et al., 1971) . Similar seroepidemiological evidence exists linking HSV to the aetiology of squamous cell carcinomas of the head and neck. Antibodies were observed in 90% of the laryngeal cancer cases, 91% of the head and neck squamous cell cancer cases, 11% of the non-squamous cell cancer cases (melanoma, breast, salivary gland, etc.), and 4 % of normal subjects (Hollingshead et al., 1973 (Hollingshead et al., , 1976 Numerous studies have attempted to detect the presence of HSV-specific markers (antigens, RNA, DNA or virions) in human tumours. Although Aurelian (1973) reported success, utilizing immunofluorescence and specific antisera directed against HSV antigens, in staining neoplastic cells exfoliated from a cervical lesion, numerous other researchers have been unable to find specific herpes antigens in their biopsies (for review, see Rawls et al., 1977) . Hybridization techniques have been utilized to detect virus nucleic acids in human tumours. Frenkel et al. (1972) reported the detection of HSV-specific DNA fragments and RNA transcripts in human cervical carcinoma tissue. Recently, Jones et al. (1978) reported detection of HSV mRNA in 5 of 8 human cervical biopsies by in situ hybridization. Besides HSV antigens and nucleic acids, entire virions have been found in tumours. One case involved a carcinoma which arose in a location on the lip which had suffered recurrent HSV lesions (Cassai et al., 1974) . Virus was isolated from this tumour and characterized as HSV.
In man, carcinoma has developed at the site of recurrent herpes labialis in a number of cases. Kvasnicka (1956) reported on an aetiological study of lower lip carcinoma in which 20% were a direct continuation of recurrent herpes labialis. Marshall (1973) , studying a group of long-term immunosuppressed patients, noted an increased incidence of HSV infection and squamous cell carcinoma Attempts to induce tumours in animals utilizing HSV have generally been unsuccessful to date (Rawls et al., 1977) . Many of these attempts utilized infectious virus and it is now believed that the cytolytic capability of HSV must be inactivated in some way in order for the virus to express its oncogenic nature. In vitro oncogenic transformation studies demonstrated that the lytic capability of HSV must be destroyed to prevent death of the host cell. Originally, Duff & Rapp (I971) utilized u.v. irradiation to inactivate the lytic functions of HSV and induce the transformation of hamster embryo fibroblasts. Numerous accounts have since documented oncogenic as well as biochemical transformation by HSV of human, rat, hamster and mouse cells (Rapp & Li, 1974; Takahashi & Yamanishi, 1974) . Other techniques to inhibit the lytic gene functions of HSV and encourage transformation include incubation of infected cells at suboptimal (20 °C) temperatures (Darai et al., 1977) , incubation at supraoptimal temperatures (Rapp & Turner, 1978) , infection with temperaturesensitive mutants (Macnab, 1974) , photodynamic inactivation with neutral red (Rapp & Li, 1974) and restriction endonuclease cleavage (Camacho & Spear, 1978) . Nucleic acid hybridization as well as enzyme analysis have been used to detect the presence of HSV proteins, mRNA and DNA in transformed cell lines and hamster tumours derived from transformed cells (Frenkel et al., 1976 , Minson et al., 1978 . However, these reports suggest that the virus DNA in transformed cells is different from that of DNA in infectious virus particles in that a full complement of DNA is not present and that DNA which is present is incapable of producing infectious progeny.
Although many lines of evidence have associated HSV with carcinoma development in man, important theoretical differences exist between association, correlation and aetiology. No evidence implying association or positive correlation of HSV with squamous cell carcinoma development can be interpreted as definite evidence of a cause and effect relationship. For this reason, this study was undertaken to investigate the cancer-causing potential of HSV in a mouse model. As previously described in detail (Kitces et al., 1977) , the mouse model consists of inoculation of virus on to the lip with resultant vesiculation, ulceration and eventual healing as long as the titre of the inoculum is low enough to prevent fatal encephalitis, In this model repeated HSV inoculation is not capable of inducing tumour formation. However, by superimposing u.v. irradiation on the HSV-infected lips, microscopic abnormalities are observed (Burns & Murray, 1978) . These lesions consist of hyperkeratosis, acanthosis and dysplasia, while the control lips that receive only u.v. exposure remain macroscopically and microscopically normal. In the present series of experiments, a tumour-promoting agent (12-O-tetradecanoyl-phorbol-acetate) was repeatedly applied to the lips of animals previously exposed to HSV inoculation and u.v. irradiation in order to convert the microscopic abnormalities into macroscopic malignancies.
METHODS
Experimental animals. Six-week-old male Balb/c mice were obtained from Laboratory Supply Company (Indianapolis, Ind., U.S.A.). Mice were housed at a maximum of 10 per cage and supplied tap water and Purina Lab Rodent Chow ad libitum. Animals were acclimated for 7 days prior to experimental manipulations. HSV-infected and uninfected mice were housed in separate biohazard facilities.
Virus. The 333 strain of HSV-2 (333) originally isolated from human lesions, was used throughout these studies. Virus stocks were prepared by infecting monolayers of human epidermoid cells (HEp-2) (m.o.i. 0.1) and harvesting when 80% of the cells showed HSV-induced cytopathic effects. The cell-associated virus was obtained by lysing the infected cells in distilled water (2 ml/T-75 flask for 30 min) and subsequent sonication for 30 s. Supernatant fluids were clarified by low-speed centrifugation. Aliquots of virus pools were stored at -70 °C. Virus infectivity was assayed on Vero cells and expressed as plaque-forming units per ml (p.f.u./ml).
Ultraviolet irradiation. Two u.v. bulbs (General Electric G15T8, 15 W) were used to deliver 42 ergs/mmZ/s of exposure as measured by a u.v. meter. In the majority of studies the u,v. exposure was directed to the ventral surface of the mice. In one study, however, the u.v. exposure was directed to a 333 virus pool prior to inoculation of the mice.
Chemicals. The tumour-promoting agent 12-O-tetradecanoyl-phorbot-13-acetate (TPA) (Consolidated Midland Corp., Brewster, N.Y., U.S.A.) was dissolved in DMSO (10 mg/ 7 ml). Ten/tl applications (0.02 amol) were delivered to the right maxillary lip three times a week (Mon., Wed., Fri). Control groups of animals receiving DMSO application without TPA were also included.
Labial inoculation of mice. Mice were anaesthetized in a closed chamber in which the atmosphere was saturated with Metophane (Pitman-Moore Inc. Washington Crossing, N.J., U.S.A.). Anaesthesia was obtained after 5 min in this environment. The right maxillary lip of the anaesthetized mouse was slightly abraded by a slow speed dental drill with a steel brush attachment. Light pressure on the mucosa with the dental brush produced erythema, but active bleeding was not produced. The abraded lip was painted with a cotton tipped stick moistened in a virus solution (approx. 100 al) or saline according to the individual experimental protocol. Lips were examined weekly under x2 magnification for herpetic and/or neoplastic lesions.
Tissue removal and evaluation. At the termination of the in vivo experiments, mice were sacrificed by chloroform inhalation and cardiac exsanguination. Sera were saved for neutralizing antibody assays. External macroscopic evaluation was carefully performed to document the presence of lip tumours. Large lip tumours were trisected and portions were treated as follows: (i) placed in a tissue embedding bag, identified by mouse number, fixed in 10% neutral-buffered formalin, and submitted for histological evaluation with haematoxylin and eosin (H & E) staining; sections were examined for evidence of virus infection or tumour formation; (ii) identified by mouse number, embedded in frozen section embedding compound (OCT), and evaluated by immunoperoxidase staining for the presence of virus antigens; (iii) explanted on to a coverslip in a 60 mm Petri dish, embedded between 1 drop of chicken embryo extract/l drop of chicken plasma, and cultured under Waymouth's media containing 10% foetal bovine serum, gentamicin and penicillin. Cellular outgrowth was also evaluated by immunoperoxidase staining.
Immunoperoxidase staining procedure. Demonstration of virus antigens in cultured cells or clinical specimens was accomplished using the immunoperoxidase stain as described by DeLellis et al. (1979) . Specimens were fixed in acetone for 10 min before staining with specific anti-HSV antisera and peroxidase-conjugated antisera (Cappell, Cochranville, Pa., U.S.A.).
Mierotitre assay of serum neutralizing antibody. Sera were obtained by cardiac puncture. Following clot formation, the sera were separated by centrifugation at 1000 g for 10 rain. Sera were heat-inactivated at 56 °C for 30 min and twofold serial dilutions (1 : 10 to 1:320) were made in a 96-well plate (Costar, Cambridge, Mass., U.S.A.). A virus suspension of strain 333 containing 100 TCIDs0 was added to each well and incubated at 36 °C for 1 h. Then, 4.0 × 10 ~ Vero cells were added to each well and incubated for 2 to 3 days. The neutralizing antibody titre of the experimental serum was expressed as the highest dilution of serum which prevented virus c.p.e.
RESULTS
An in vivo experiment, analogous to in vitro transformation by u.v.-irradiated HSV, was designed to investigate the effects of HSV infection, u.v. irradiation and promotion by TPA. Since three variables were involved in the experimental group, necessary control group s included HSV infection alone, u.v. exposure alone, repeated TPA application alone and combinations of any two variables. The results are summarized in Table 1 .
Those mice inoculated with infectious virus (HSV only) developed typical vesicular~ ulcerative lesions within 3 days. Eight days after inoculation, the lesions encrusted and proceeded to totally heal.
Ultraviolet irradiation, often utilized for in vitro transformation experiments with HSV, was delivered daily for 4 days to the ventral surface of anaesthetized mice for 6 rain (u.v. only). At the exposure utilized, tumours failed to develop and the lips retained their normal macroscopic and microscopic appearance.
Tetradecanoyl-phorbol-acetate (TPA), a macrocyclic diterpene ester, has commonly been used in the past to promote an earlier emergence of chemically induced experimental tumours (two-stage carcinogenesis) (Van Duuren, 1969) . In our studies, the repeated application of TPA (0.02 pmol in 10 pl DMSO) to the maxillary lips of mice caused no tumours to emerge at the concentration and frequency of application utilized.
Papillomas arose in a few of the mice treated with combinations of any two variables. For example, when animals were infected with HSV on the lip and exposed to u.v. irradiation on days 3 to 6 post-inoculation (HSV + u.v.) one of 19 mice developed a papilloma at the inoculation site. Significantly, when the order was reversed no tumours emerged (u.v.-HSV). In that experiment, a virus inoculum was irradiated for 6 rain at 42 ergs/mm2/s prior to its application on to abraded lips of mice. Small papillomas also arose when animals were exposed to u.v. irradiation and repeated TPA application (u.v. + TPA) or when animals were infected with an HSV inoculum and then received repeated TPA application (HSV + TPA). In either case the latent period before turnout emergence was 13 weeks and the tumour incidence was 4 % and 6 % respectively.
In the experimental group, 182 mice were subjected to HSV lip inoculation, u.v. exposure on days 3, 4, 5, 6, and TPA applications three times a week beginning on day 9 for the duration of the experiment (Table I) . Ninety-six percent of these animals developed typical herpetic lip lesions by 5 days post-inoculation. Within this group, 32 mice developed lip tumours at the site of HSV infection. The average period of time for these tumours to emerge was 10.8 weeks. At the termination of the experiment 193 days after HSV inoculation, histological examination of these tumours revealed 24 benign papillomas, 2 epithelial dysplasias, and 6 squamous cell carcinomas. A comparison of the experimental group with * Seven-week-old male Balb/c mice were anaesthetized and their maxillary right lip abraded and exposed to: (i) HSV-2 strain 333 (0.1 ml of a stock solution 1-3 × 107 p.f.u./ml) applied on day 0; (ii) u.v. only, 42 ergs/mm2/s for 6 min daily on days 3 to 6; (iii) TPA only, 0-02 #mol in 10 ~1 DMSO, 3 times a week starting on day 9; (iv) u.v. + TPA, applied-as described above; (v) u.v.-HSV, virus inoculum irradiated (42 ergs/mm2/s) for 6 min prior to application; (vi) HSV + u.v. applied as described above; (vii) HSV + TPA, applied as described above; (viii) HSV + u.v. + TPA, applied as described above. the remaining 263 surviving control animals revealed that squamous cell carcinomas developed only in the group receiving HSV, u.v. and TPA (Table 1) (P < 0.03). Also, papillomas developed more frequently in the experimental group (P < 0.001). In addition, tumours arose earlier in this group (10-8 weeks) as compared to the control groups (13 to 24 weeks). At the termination of this experiment, a total of 38 lip tumours that had developed in the experimental as well as control groups were surgically removed. Many of the tumours were not large enough to trisect for: (i) formalin fixation and paraffin embedding, (ii) cryostat sectioning, and (iii) explantation to tissue culture. Therefore, priorities for evaluations were set. The first priority was to obtain a histological diagnosis utilizing H & E-stained paraffin-embedded tissues. The diagnoses are presented in Table 1 . The next priority was to examine the tumour cells for the presence of HSV antigens utilizing the immunoperoxidase stain. Twenty-one of the 38 lip tumours were large enough to hemisect and freeze one portion for cryostat sectioning. Eleven of the tumours were even larger and were trisected; one portion explanted to tissue culture in vitro. Five of these attempted explants successfully grew out on to coverslips. In both instances, cells were eventually fixed and stained utilizing the immunoperoxidase stain as were positive and negative control tissues and cells. Results are presented in Table 2 . When the primary antiserum of the immunoperoxidase stain was rabbit a-HSV-2 strain MS, four tissue specimens stained for HSV antigens. These specimens were from three animals of the HSV + u.v. + TPA group. When hamster a-333 antiserum was used as the primary antiserum, six specimens stained positive. In addition, these six specimens stained positive when mouse a-333 antiserum or antiserum from the HSV + u.v. + TPA-induced turnout-bearing animals was used as the primary antisera. In all instances these specimens came from animals of the HSV + u.v. + TPA group, suggesting a role for HSV in the development of these tumours. 
* Four different antisera were used as the primary serum in the immunoperoxidase staining. "t" Details of the treatment are found in Table 1 Table 1 for details of treatment. "1" Serum-neutralizing antibody titres for each mouse were determined by microtitre analysis as described in Methods.
:[: Statistical analysis, standard deviation (s.o.) and standard error (S.E.), calculated according to Genozian et aL (1958) utilizing the Student's t-test. § P < 0.001.
The serum from each animal was analysed by microtitre assay for neutralizing antibodies.
The mean serum HSV-neutralizing antibody titre for each of the groups is presented in Table   3 . Antibodies to HSV were not found in mice which had not been infected with HSV. Of those groups that had been inoculated on the lip with HSV, the mean antibody titre ranged from 1 : 14-7 to 1 : 18.4. Statistical analysis of these titres utilizing Student's t-test revealed no significant differences between the groups. However, within one group (HSV + u.v. + TPA), when the titres from the tumour-bearing animals were compared to those of nontumour-bearing animals, a highly significant difference emerged (P < 0.001)., Those animals which developed papillomas and carcinomas had an increased antibody titre against HSV (1:28.6) as compared to those animals without tumours (1:16.3). Further subdivision and comparison of titres from papilloma-bearing (1:27-6)versus carcinoma-bearing (1:30.0) animals failed to yield significant differences, although the carcinoma group had slightly greater titres.
DISCUSSION
Certain herpes viruses have been associated with human neoplasias (Burkitt's lymphoma and nasopharyngeal carcinoma), but the role of HSV in the development of human cancer has been very difficult to demonstrate due to the frequency with which this virus is found in the general population and the relative rarity of squamous cell carcinoma development in the same population (Rapp & Reed, 1977) . The transforming event may be quite infrequent due to the inefficiency of the 'oncogenic' virus or the extreme sensitivity of the host defence mechanisms. A more likely explanation is that the neoplastic transforming process is a very complex series of events and HSV may act in concert with other factors to induce cancer. Therefore, an in vivo model was designed combining HSV infection with exposure to certain environmental cofactors (u.v. irradiation with or without a tumour-promoting agent). Prior to this model, the only in vivo evidence for the role of HSV in oncogenesis was by the subcutaneous injection of cells transformed by HSV in vitro.
Malignant neoplasms require the survival and uncontrolled replication of individual cells in order to continually increase in size. Therefore, an alteration in the normal cytolytic course of HSV infection must occur in order for the host cell to survive and undergo malignant transformation. We have previously shown that repeated HSV infections failed to induce tumour development on mouse lips, even though repeated exposure or persistent infections by HSV have been hypothesized as a possible mechanism for oncogenic transformation (Rawls et al., 1977) . The hypotheses state that HSV latency, repeated reactivation or defective virus production might produce alteration of the virus genome, thus inhibiting the lytic functions of HSV and allowing expression of the oncogenic capability. However, in the studies reported here, it appears to be necessary to inhibit the lytic functions of HSV by u.v. irradiation. An optimal exposure time to u.v. radiation must exist in order to inactivate HSV infectivity. Duff & Rapp (1975) have previously presented data to show that 6 to 8 min of u.v. exposure results in maximal transformation in vitro. When HSV was irradiated for 6 min before inoculation on the lips of mice (u.v.-HSV) no herpetic lesions or tumours arose (Table 1) . Thus, a gene function necessary for HSV infectivity was inactivated by exposure to u.v. radiation. However, when the u.v. exposure was delivered in vivo on days 3, 4, 5 and 6 post-inoculation when virus titres were maximal in the lip tissues, microscopic abnormalities including epithelial dysplasia and hyperplasia developed (Burns & Murray, 1978) . Furthermore, malignant tumours developed only when the repeated application of TPA was added to the HSV + u.v. protocol. This emphasizes the possible multi-stepped and multi-factorial nature of carcinogenesis, as well as the common requirement for initiation and promotion delivered in a particular sequence. The results obtained in these studies show that squamous cell carcinomas do develop after HSV + u.v. + TPA exposure (Table 1) . These represent the first data implicating HSV as a co-carcinogen in an animal model. Analogous to the classical two-stage carcinogenesis model, the combination of HSV infection and u.v. irradiation on the days of maximum tissue titre was considered the initiator and TPA the promoter.
Important theoretical explanations emerge when HSV + u.v. is considered the initiating agent since most studies currently view alterations of cellular DNA as the most attractive mechanism for the initiation of the carcinogenic process. One explanation would be that u.v. irradiation acts as a mutagen inducing DNA alterations as described by Parrish (1978) and that HSV acts as an inhibitor of DNA repair by disruption of host DNA as described by Aurelian (1973) . However, another explanation could be that u.v. irradiation simply destroys the cytolytic capabilities of HSV and allows the virus to express its inherent oncogenic capability. We prefer the later explanation for several reasons. Analysis of the serumneutralizing antibody titres from the mice in the HSV + u.v. + TPA group showed a significant increase among those animals bearing tumours (Table 3 ). In addition, four of these tumours (three papillomas and one squamous cell carcinoma) stained positive for the presence of HSV antigens by immunoperoxidase staining ( Table 2 ). The increased antibody titres in tumour-bearing mice and the presence of HSV antigens in these tumours implied a relationship between HSV and tumour development. In summary, these data suggest that HSV contributed in a positive way to the development of squamous cell carcinomas following HSV + u.v. + TPA treatment and, in that regard, may be considered a co-carcinogen.
